INVO Bioscience Inc
NASDAQ:INVO
Intrinsic Value
INVO BioScience, Inc. focuses on the creation of treatment options for patients diagnosed with infertility. [ Read More ]
The intrinsic value of one INVO stock under the Base Case scenario is 29.23 USD. Compared to the current market price of 1.13 USD, INVO Bioscience Inc is Undervalued by 96%.
Fundamental Analysis
Our AI Assistant is coming soon! Stay tuned and thank you for your interest!
Provide an overview
of INVO Bioscience Inc's business.
What risks and challenges
does INVO Bioscience Inc face in the near future?
Summarize the latest earnings report
of INVO Bioscience Inc.
Provide P/E
for INVO Bioscience Inc and its competitors.
Balance Sheet Decomposition
INVO Bioscience Inc
Current Assets | 1.8m |
Cash & Short-Term Investments | 1.1m |
Receivables | 120k |
Other Current Assets | 610k |
Non-Current Assets | 17.7m |
Long-Term Investments | 1.1m |
PP&E | 6.6m |
Intangibles | 10m |
Other Non-Current Assets | 10k |
Current Liabilities | 4.9m |
Accounts Payable | 1.9m |
Accrued Liabilities | 980k |
Short-Term Debt | 880k |
Other Current Liabilities | 1.2m |
Non-Current Liabilities | 14.2m |
Long-Term Debt | 1.1m |
Other Non-Current Liabilities | 13.1m |
Earnings Waterfall
INVO Bioscience Inc
Revenue
|
1.9m
USD
|
Cost of Revenue
|
-970k
USD
|
Gross Profit
|
950k
USD
|
Operating Expenses
|
-8.9m
USD
|
Operating Income
|
-8m
USD
|
Other Expenses
|
-820k
USD
|
Net Income
|
-8.8m
USD
|
Free Cash Flow Analysis
INVO Bioscience Inc
What is Free Cash Flow?
INVO Profitability Score
Profitability Due Diligence
INVO Bioscience Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.
Score
INVO Bioscience Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.
INVO Solvency Score
Solvency Due Diligence
INVO Bioscience Inc's solvency score is 17/100. The higher the solvency score, the more solvent the company is.
Score
INVO Bioscience Inc's solvency score is 17/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
INVO Price Targets Summary
INVO Bioscience Inc
Ownership
INVO Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
INVO Price
INVO Bioscience Inc
Average Annual Return | -46.21% |
Standard Deviation of Annual Returns | 39.1% |
Max Drawdown | -100% |
Market Capitalization | 2.8m USD |
Shares Outstanding | 2 492 530 |
Percentage of Shares Shorted | 0.45% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
INVO BioScience, Inc. focuses on the creation of treatment options for patients diagnosed with infertility. The company is headquartered in Lakewood Ranch, Florida and currently employs 10 full-time employees. The company went IPO on 2008-11-11. The firm is focused on expanding the assisted reproductive technology (ART) marketplace by making fertility care accessible and inclusive to people around the world. Its flagship product is INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. Its treatment solution is the intravaginal culture technique for the incubation of oocytes and sperm during fertilization and early embryo development. Its INVOcells inner chamber holds egg and sperm in a culture medium. Its INVO Centers offer the INVOcell and intravaginal culture (IVC) procedure, in addition to its selling of technology solutions into existing fertility clinics. The firm's subsidiaries include Bio X Cell, Inc., and Invo Centers, LLC.